Late yesterday, the Federal Circuit released a nonprecedential order dismissing a petition. This morning the court released three nonprecedential opinions and three nonprecedential orders. One of the nonprecedential opinions comes in a patent case appealed from the Patent Trial and Appeal Board, one comes in a case appealed from the Court of Appeals for Veterans Claims, and one comes in a patent case appealed from the Northern District of California. The three nonprecedential orders dismiss appeals. Here are the introductions to the opinions as well as links to the dismissals.
Pfizer Inc. v. Sanofi Vaccines US Inc. (Nonprecedential)
This case comes back to us after we previously remanded it for the Patent Trial and Appeal Board (“the Board”) to consider, in its inter partes review (“IPR”) proceeding, the patentability of proposed substitute claims 48 and 49 of Pfizer Inc.’s (“Pfizer’s”) U.S. Patent 9,492,559 (“the ’559 patent”). On remand, the Board determined in a final written decision that those proposed substitute claims would have been obvious over certain prior art publications and therefore denied Pfizer’s motion to amend its claims. Sanofi Pasteur Inc. v. Pfizer Inc., Nos. IPR2018-00187, IPR2017-02131, IPR2017-02132, 2024 WL 2927019 (P.T.A.B. June 10, 2024) (“Decision”), J.A. 71–105.1 For the following reasons, we affirm.
Shelton v. Collins (Nonprecedential)
Michael F. Shelton appeals a decision of the Court of Appeals for Veterans Claims (Veterans Court) affirming a Board of Veterans’ Appeals (Board) denial of his application for total disability based on individual unemployability (TDIU). We dismiss for lack of jurisdiction.
Regents of the University of Michigan v. Leica Microsystems, Inc. (Nonprecedential)
The Regents of the University of Michigan (“Michigan”) appeals from a decision of the U.S. District Court for the Northern District of California granting Leica Microsystems, Inc.’s (“Leica”) motion for summary judgment of noninfringement. For the following reasons, we affirm.